BLOOD TRANSFUSION《输血》(可官网投稿)

BLOOD TRANSFUSION《输血》(双月刊). Blood Transfusion (BT) is a bimonthly, peer-reviewed Journal founded in 1956 by the Italian Society of Transfusion Medicine and Immunohaematology (Società Italiana di Medicina Trasfusionale e Immunoematologia, SIMTI). It is the official journal of SIMTI, Italian Association of Haemophilia Centres (Associazione Italiana dei Centri Emofilia, AICE), Croatian Society of Transfusion Medicine (Hrvatsko Društvo za Transfuzijsku Medicinu, HDTM) and Spanish Society of Blood Transfusion and Cellular Therapy (Sociedad Española de Transfusión Sanguinea y Terapia Celular, SETS).

杂志简称:blood transfus、italy
中文译名:《输血》
收录属性:scie(2024版), 目次收录(维普), 目次收录(知网),英文期刊,
自引率:5.50%
投稿方向:医学、hematology血液学

BLOOD TRANSFUSION《输血》

SCI/E期刊基本信息

出版周期:双月刊 地区:意大利
中科院分区:3区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:OA期刊
国际标准刊号:ISSN 1723-2007;EISSN 1723-2007
杂志语言:英语
出版国家:意大利

杂志官网 联系方式

出版地址:VIA DESIDERIO 21,MILAN,ITALY,20131
杂志邮箱:
投稿网址:https://www.bloodtransfusion.it/bt-subm1.aspx
杂志官方网址:https://www.bloodtransfusion.it/Index.aspx
出版商网址:

杂志投稿要求

投稿须知【杂志社官方网站信息】

Blood Transfusion

INSTRUCTIONS FOR AUTHORS (15 December 2021)

1. GENERAL INFORMATION

The aims and scope of Blood Transfusion are available on the Journal’s website (http://www.bloodtransfusion.it/Finalita.aspx).

All manuscripts must be submitted online (http://www.bloodtransfusion.it/bt-subm1.aspx). Manuscripts submitted by e-mail will not be considered. Blood Transfusion’s website is optimised for Google Chrome. For technical problems related to submissions, you may contact the Editorial Office (luisa.stea@bloodtransfusion.it).

To speed up the review process, please submit manuscripts with the required editing style.

Blood Transfusion follows the International Committee of Medical Journal Editors (ICMJE) Recommendations (www.icmje.org/recommendations/). ICMJE provides useful guidelines on manuscript preparation (http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html.

Blood Transfusion gives priority to reports of original research that are likely to change clinical practice or thinking about a disease.

1.1. Copyright

Authors will grant copyright of their manuscript to SIMTIPRO Srl. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is cited appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties. Please contact the Publisher for requests: francesca.termine@simtipro.it.

1.2. Language

All manuscripts must be written in English.

1.3. Peer review

All submissions are subject to peer-review by experts selected by the Editor-in-Chief and the Associate Editors.

Once an article has been submitted, the corresponding Author will receive an e-mail indicating the submission number. Please make sure that this submission number is cited in all correspondence with the Editor or Editorial Office.

The review process takes about 6 weeks, and most manuscripts require revision before final acceptance.

Each paper is first evaluated by one or more Editors, who will assess the overall quality and novelty of the work and the article's appropriateness for the scope of Blood Transfusion. Articles that are not found relevant or do not fulfil the primary goals of Blood Transfusion will not be sent out for external review. Articles considered of interest to the Journal are reviewed by external Reviewers (second step of the classical peer-review).

The Reviewers’ comments are returned to the Editor who, taking into account the Reviewers’ comments, may approve (with minor or major modifications) or reject the article. In either case the Editor informs the Author of the editorial decision.

Authors who submit a revised version according to the Reviewers’ comments, must log-into Blood Transfusion’s website again and replace the files, together with the responses to the Reviewers’ observations. Authors who do not agree with the Reviewers’ observations must clearly state their reasons. It is up to the Editors to accept such reasons.

A copy of the manuscript with highlighted changes in the text is required to help speed the review process. Revised papers are reviewed by the original Reviewers, unless the Editor-in-Chief or the Associate Editor opt for an immediate decision. Acceptance of a revised paper is not assured, but is dependent on the suitability of the responses to and compliance with the Reviewers’ comments. The final decision on a paper's acceptability for publication is made by the Editor-in-Chief on the basis of the comments of the Associate Editor and the Reviewers. A summary of the peer review process is illustrated in the flow chart.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/48510

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 下午12:37
下一篇 2024年11月9日 下午12:37

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息